Lymph node dissection in curative gastrectomy for advanced gastric cancer (Q40584507)

21 September 2017

Lymph node dissection in curative gastrectomy for advanced gastric cancer (English)

1 reference

21 September 2017

0 references

Shigeyuki Tamura

1

1 reference

21 September 2017

Atsushi Takeno

series ordinal

2

1 reference

21 September 2017

Hirofumi Miki

series ordinal

3

1 reference

21 September 2017

14 June 2011

1 reference

International Journal of Surgical Oncology

21 September 2017

1 reference

21 September 2017

2011

1 reference

21 September 2017

748745

1 reference

Creative Commons Attribution 3.0 Unported

21 September 2017

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Meta-analysis of effectiveness and safety of D2 plus para-aortic lymphadenectomy for resectable gastric cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Results and controversial issues regarding a para-aortic lymph node dissection for advanced gastric cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Estimates of the worldwide mortality from 25 cancers in 1990.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Splenectomy for treatment of gastric cancer: Japanese experience

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Pancreas‐preserving total gastrectomy for proximal gastric cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Radical surgery for gastric cancer. A review of the Japanese experience

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Lack of benefit of combined pancreaticosplenectomy in D2 resection for proximal-third gastric carcinoma.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Effectiveness of paraaortic lymph node dissection for advanced gastric cancer

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3263688

Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501

20 August 2018

1 reference

12 December 2020

Nodal dissection for patients with gastric cancer: a randomised controlled trial

1 reference

12 December 2020

Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial

1 reference

12 December 2020

Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial

1 reference

12 December 2020

A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma

1 reference

12 December 2020

Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer

1 reference

12 December 2020

Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients

1 reference

12 December 2020

Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study

1 reference

12 December 2020

Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study

1 reference

12 December 2020

[Perioperative chemotherapy vs. surgery alone in resectable gastroesophageal carcinomas. Results of the MAGIC study]

1 reference

12 December 2020

Splenectomy in cancer gastrectomy: recommendation of spleen-preserving for early stages

1 reference

12 December 2020

Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach

1 reference

12 December 2020

Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients

1 reference

12 December 2020

Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial

1 reference

12 December 2020

Evaluation of the extent of lymphadenectomy in a randomized trial of Western- versus Japanese-type surgery in gastric cancer

1 reference

12 December 2020

Lymph node metastasis at the splenic hilum in proximal gastric cancer

1 reference

12 December 2020

The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification

1 reference

12 December 2020

D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer

1 reference

12 December 2020

Should systematic lymph node dissection be recommended for gastric cancer?

1 reference

12 December 2020

Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons

1 reference

12 December 2020

Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial

1 reference

12 December 2020

Total gastrectomy with dissection of lymph nodes along the splenic artery: a pancreas-preserving method

1 reference

12 December 2020

Surgery and clinicopathological features of gastric adenocarcinoma involving the esophago-gastric junction

1 reference

12 December 2020

Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement

1 reference

12 December 2020

Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial

1 reference

12 December 2020

Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial

1 reference

12 December 2020

Identifiers

DOI

10.1155/2011/748745

1 reference

21 September 2017

1 reference

21 September 2017

PubMed publication ID

22312521

1 reference